Last checked at 17 Oct 2016 15:15
For immediate release 17 October 2016
NANOCO GROUP PLC
("Nanoco" or the "Company" or "Group")
Director Share Purchase
Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other nanomaterials, received notification today that Dr Christopher Richards, Non-Executive Chairman, purchased 19,833 ordinary shares of £0.10 each ("Ordinary Shares") in the Company on 17 October 2016 at a price of 50.42p per Ordinary Share.
Following this transaction, Christopher has a beneficial interest in 118,830 Ordinary Shares (of which 73,120 are held by his wife, Ann Carolyn Richards), representing approximately 0.05 per cent. of the total voting rights in the Company.
The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.
1 | Details of the person discharging managerial responsibilities/person closely associated
| |
a) | Name | Christopher Richards
|
2 | Reason for the notification
| |
a) | Position/status
| Non-Executive Chairman |
b) | Initial notification/Amendment
| Initial notification |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |
a) | Name
| Nanoco Group plc |
b) | LEI | England & Wales Company Number: 05067291
|
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |
a) | Description of the financial instrument, type of instrument
| Ordinary Shares |
| Identification code | NANO
ISIN GB00B01JLR99
|
b) | Nature of the transaction | Acquisition of Ordinary Shares
|
c) | Price(s) and volume(s)
| Price(s) 50.42p Volume(s) 19,833
|
d) | Aggregated information
| Price(s) 50.42p Volume(s) 19,833
|
e) | Date of transaction | 17 October 2016
|
f) | Place of transaction | London Stock Exchange
|
For further information, please contact:
Nanoco |
|
Michael Edelman, Chief Executive Officer | Tel: +44 (0) 161 603 7900 |
David Blain, Chief Financial Officer |
|
Caroline Watson, Investor Relations Manager | Tel: + 44 (0) 7799 897357 |
cwatson@nanocotechnologies.com |
|
Peel Hunt |
|
Adrian Trimmings / George Sellar / Alex Lomax | Tel: +44 (0) 20 7418 8900 |
Buchanan |
|
Mark Court / Sophie Cowles / Stephanie Watson | Tel: +44 (0) 20 7466 5000 |
Notes for editors:
About Nanoco Group plc
Nanoco is a world leader in the development and production of cadmium-free quantum dots and other nanomaterials for use in multiple applications including LCD displays, lighting, solar cells and bio-imaging. In the display market, Nanoco has non-exclusive manufacturing and marketing licensing agreements with The Dow Chemical Company, Merck KGaA and Taiwan's Wah Hong Industrial Corporation. Nanoco also has a strategy of direct sales in display and in its other target markets, including lighting.
Nanoco was founded in 2001 and is headquartered in Manchester, UK. It has production facilities in Runcorn, UK, and a US subsidiary, Nanoco Inc, based in Concord, MA. Nanoco also has business development executives in Japan, Korea and Greater China. Its technology is protected worldwide by a large and growing patent estate.
Nanoco is listed on the main market of the London Stock Exchange and trades under the ticker symbol NANO. For further information please visit: www.nanocogroup.com.